Development Level

Tbio 103 | 11,445
Tchem 6 | 1,598
Tclin 6 | 613
Tdark 1 | 6,588

IMPC Phenotype

abnormal heart morphology 1 | 162
abnormal lung morphology 1 | 26
abnormal seminal vesicle morph... 1 | 114
decreased T cell number 1 | 15
decreased heart weight 1 | 27
decreased lymphocyte cell numb... 1 | 83
decreased monocyte cell number 1 | 8
decreased vertical activity 1 | 208
embryonic lethality prior to o... 1 | 239
embryonic lethality prior to t... 1 | 278
enlarged heart 1 | 210
increased CD4-positive, alpha ... 1 | 4
increased erythrocyte cell num... 1 | 39
increased leukocyte cell numbe... 1 | 47
increased lymphocyte cell numb... 1 | 32
increased monocyte cell number 1 | 63
increased neutrophil cell numb... 1 | 46
short tibia 1 | 97
vertebral fusion 1 | 23

Disease

Cancer 87 | 2,499
diabetes mellitus 79 | 1,728
Hypersensitivity reaction type II disease 75 | 253
Ankylosing spondylitis 73 | 140
Behcet's disease 70 | 89
psoriasis 68 | 6,694
Arthritis 66 | 290
Rheumatoid arthritis 66 | 1,191
Juvenile rheumatoid arthritis 65 | 111
Uveitis 63 | 103
Acquired immunodeficiency syndrome 62 | 197
Herpes zoster 59 | 68
Human immunodeficiency virus infectious disease 56 | 138
Psoriatic arthritis 55 | 86
Stevens-Johnson syndrome 52 | 92
Dermatitis 46 | 157
Multiple Sclerosis 44 | 540
Carcinoma 43 | 11,493
dermatomyositis 42 | 966
tuberculosis 39 | 2,010
Behcet's syndrome 38 | 50
Synovitis 37 | 78
Takayasu's arteritis 37 | 53
Nephritis 36 | 51
Congenital adrenal hyperplasia 35 | 73
Retinal vasculitis 35 | 36
Spondyloarthropathy, Susceptibility To, 1 35 | 35
drug-induced hepatitis 35 | 44
Hepatitis B 34 | 108
Anemia 31 | 365
Leprosy 30 | 73
Primary immunodeficiency disease 30 | 54
Kidney disease 29 | 430
Liver disease 29 | 237
Hemochromatosis 23 | 54
Skin disease 22 | 66
sarcoidosis 22 | 370
Birdshot chorioretinopathy 21 | 23
lung cancer 19 | 4,740
lung carcinoma 19 | 2,843
Systemic lupus erythematosus 18 | 194
Berylliosis 17 | 28
Narcolepsy 17 | 72
Asthma 16 | 385
Human immunodeficiency virus type 1, susceptibility to 16 | 26
Pre-Eclampsia 15 | 68
Schizophrenia 15 | 1,160
glioblastoma 15 | 5,792
interstitial cystitis 15 | 2,312
Astrocytoma, Pilocytic 14 | 3,081
Multiple Sclerosis, Susceptibility to 14 | 15
Narcolepsy-cataplexy 14 | 21
Psoriasis susceptibility 1 14 | 14
Vasculitis 14 | 80
cutaneous lupus erythematosus 14 | 1,057
ovarian cancer 14 | 8,520
Diffuse cutaneous systemic sclerosis 13 | 17
Rheumatoid Arthritis, Systemic Juvenile 13 | 16
Sarcoidosis 1 13 | 14
follicular lymphoma 13 | 20
limited scleroderma 13 | 19
osteosarcoma 13 | 7,950
subependymal giant cell astrocytoma 13 | 2,287
Inflammatory bowel disease 12 | 151
Influenza 11 | 142
non-small cell lung cancer 11 | 2,890
Allergic hypersensitivity disease 10 | 126
Fever 10 | 138
Hypersensitivity 10 | 63
Tetanus 10 | 68
active Crohn's disease 10 | 922
adult high grade glioma 10 | 3,801
invasive ductal carcinoma 10 | 2,951
ulcerative colitis 10 | 1,819
Arthritis, Rheumatoid 9 | 174
Autistic Disorder 9 | 364
Leishmaniasis 9 | 47
Type 1 diabetes mellitus 9 | 109
breast carcinoma 9 | 1,638
juvenile dermatomyositis 9 | 1,187
malignant mesothelioma 9 | 3,232
primary Sjogren syndrome 9 | 735
Autoimmune Diseases 8 | 67
Crohn's disease 8 | 321
Duchenne muscular dystrophy 8 | 601
Hypereosinophilic syndrome 8 | 71
Leukopenia 8 | 72
Malaria 8 | 160
Meningitis 8 | 67
Urticaria 8 | 67
active ulcerative colitis 8 | 764
intraductal papillary-mucinous carcinoma (IPMC) 8 | 2,989
Celiac disease 7 | 116
Chemical and Drug Induced Liver Injury 7 | 195
Collagen disease 7 | 27
Fatigue 7 | 182
Lung disease 7 | 142
Thrombocytopenia 7 | 197
Weight decreased 7 | 103
astrocytoma 7 | 1,146

Tissue

Liver and Pancreas 33 | 16,750
Blood and immune system 32 | 16,909
Digestive Tract 32 | 17,369
Female tissues 32 | 17,400
Respiratory system 32 | 16,393
Skin and soft tissues 32 | 17,230
Endocrine System 31 | 18,159
Male tissues 31 | 17,142
Urinary Tract 30 | 16,678
Cardiovascular System 26 | 15,192
Nervous System 26 | 16,725

Target Family

Non-IDG 115 | 12,091
Enzyme 1 | 4,145

KEGG Pathway

Allograft rejection 116 | 116
Metabolic pathways 1,263 | 1,263
Pathways in cancer 530 | 530
Olfactory transduction 414 | 414
Human papillomavirus infection 388 | 388
PI3K-Akt signaling pathway 349 | 349
HTLV-I infection 336 | 336
Endocytosis 310 | 310
MAPK signaling pathway 295 | 295
Epstein-Barr virus infection 280 | 280
Neuroactive ligand-receptor in... 276 | 276
Cytokine-cytokine receptor int... 267 | 267
Herpes simplex infection 262 | 262
Kaposi's sarcoma-associated he... 252 | 252
Viral carcinogenesis 251 | 251
Thermogenesis 232 | 232
Ras signaling pathway 230 | 230
Phagosome 229 | 229
Cellular senescence 228 | 228
Cell adhesion molecules (CAMs) 225 | 225
Rap1 signaling pathway 209 | 209
Regulation of actin cytoskelet... 207 | 207
cAMP signaling pathway 201 | 201
Focal adhesion 198 | 198
Proteoglycans in cancer 198 | 198
Natural killer cell mediated c... 197 | 197
Huntington's disease 194 | 194
Tuberculosis 189 | 189
Calcium signaling pathway 183 | 183
Chemokine signaling pathway 183 | 183
Influenza A 182 | 182
Axon guidance 174 | 174
Purine metabolism 172 | 172
Alzheimer's disease 171 | 171
Transcriptional misregulation ... 171 | 171
Tight junction 169 | 169
Hepatocellular carcinoma 168 | 168
NOD-like receptor signaling pa... 166 | 166
Protein processing in endoplas... 164 | 164
RNA transport 163 | 163
cGMP-PKG signaling pathway 162 | 162
Jak-STAT signaling pathway 161 | 161
Cushing's syndrome 158 | 158
Antigen processing and present... 156 | 156
Hippo signaling pathway 154 | 154
Necroptosis 154 | 154
Oxytocin signaling pathway 154 | 154
MicroRNAs in cancer 150 | 150
mTOR signaling pathway 150 | 150
Non-alcoholic fatty liver dise... 149 | 149
Gastric cancer 148 | 148
Retrograde endocannabinoid sig... 148 | 148
Adrenergic signaling in cardio... 147 | 147
Alcoholism 147 | 147
Breast cancer 147 | 147
Phospholipase D signaling path... 147 | 147
Wnt signaling pathway 145 | 145
Hepatitis B 143 | 143
Parkinson's disease 142 | 142
Estrogen signaling pathway 139 | 139
Apoptosis 138 | 138
Fluid shear stress and atheros... 138 | 138
Signaling pathways regulating ... 138 | 138
Insulin signaling pathway 137 | 137
Ubiquitin mediated proteolysis 137 | 137
Viral myocarditis 137 | 137
Apelin signaling pathway 136 | 136
Dopaminergic synapse 135 | 135
Ribosome 134 | 134
Measles 133 | 133
Oxidative phosphorylation 133 | 133
Relaxin signaling pathway 133 | 133
Spliceosome 132 | 132
Autoimmune thyroid disease 130 | 130
FoxO signaling pathway 130 | 130
Hepatitis C 130 | 130
Autophagy - animal 128 | 128
Osteoclast differentiation 127 | 127
Cell cycle 125 | 125
Platelet activation 125 | 125
Toxoplasmosis 125 | 125
Lysosome 123 | 123
Vascular smooth muscle contrac... 123 | 123
Type I diabetes mellitus 122 | 122
Oocyte meiosis 121 | 121
AMPK signaling pathway 120 | 120
Graft-versus-host disease 120 | 120
Neurotrophin signaling pathway 119 | 119
Th17 cell differentiation 119 | 119
Sphingolipid signaling pathway 118 | 118
Carbon metabolism 116 | 116
Glutamatergic synapse 116 | 116
Thyroid hormone signaling path... 116 | 116
Serotonergic synapse 114 | 114
Leukocyte transendothelial mig... 112 | 112
Cholinergic synapse 111 | 111
Hematopoietic cell lineage 108 | 108
Systemic lupus erythematosus 108 | 108
TNF signaling pathway 108 | 108
Insulin resistance 107 | 107

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
HLA class I histocompatibility antigen, B-35 alpha chain HLA-B Tbio Non-IDG -1.88752 1613.5 0
CD40 ligand CD40LG Tbio Non-IDG -4.58203 37578.3 1461
HLA class I histocompatibility antigen, A-80 alpha chain HLA-A Tbio Non-IDG -2.41667 4123.8 0
Perforin-1 PRF1 Tchem Non-IDG -3.20526 1546.3 367
HLA class II histocompatibility antigen, DRB1-14 beta chain HLA-DRB1 Tbio Non-IDG 0.00000 489
HLA class I histocompatibility antigen, Cw-17 alpha chain HLA-C Tbio Non-IDG -1.90661 830.5 0
HLA class I histocompatibility antigen, Cw-15 alpha chain HLA-C Tbio Non-IDG -1.90661 830.5 0
HLA class II histocompatibility antigen, DRB1-9 beta chain HLA-DRB1 Tbio Non-IDG 0.00000 0
HLA class I histocompatibility antigen, B-40 alpha chain HLA-B Tbio Non-IDG -1.88752 1613.5 0
Interleukin-4 IL4 Tbio Non-IDG -3.98318 9219.0 1325